T1	Participants 466 719	129 eyes; 31 had pseudoexfoliation syndrome (PXS), 37 had pseudoexfoliation glaucoma (PXG), 31 eyes were the fellow eyes of subjects with unilateral pseudoexfoliation syndrome (subclinical PXS) and 30 eyes were the eyes of subjects without PXS (controls
T2	Participants 722 804	Patients underwent Pentacam analysis and IOP measurement before and after dilation
T3	Participants 406 457	129 eyes of 129 patients were included in the study
T4	Participants 260 375	patients with and without pseudoexfoliation, after topical application of phenylephrine HCl 10% and tropicamide 1%.
